Gary Bridger
Director, Neurogene Inc.
Companies
- X4 Pharmaceuticals, IncBoard member Mar 14, 2019 to now1
- Neurogene Inc.Board member Mar 6, 2014 to May 9, 20182
- Xenon PharmaceuticalsEVP, Research & Development Nov 4, 2014 to Nov 25, 20143
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- X4 Pharmaceuticals, Inc XFOR4,722 shares4$12.1K at $2.56Jun 9, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 9, 2025Granted 1,500 shares of X4 Pharmaceuticals, Inc4
- Jun 10, 2024Granted 45,000 shares of X4 Pharmaceuticals, Inc5
- Jun 13, 2023Granted 45,000 shares of X4 Pharmaceuticals, Inc6
- Jun 6, 2022Granted 6,667 shares of X4 Pharmaceuticals, Inc7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARNeurogene Inc., Board member
- 3
- 4
- 5SEC EDGARForm 4 filed Jun 11, 2024
- 6SEC EDGARForm 4 filed Jun 14, 2023
- 7SEC EDGARForm 4 filed Jun 27, 2022